🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the manufacturers of Tylenol, alleging the firms withheld alleged dangers that the pain reliever presented to pediatric brain development.

The court filing follows a month after Former President Trump publicized an unsubstantiated connection between taking Tylenol - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in young ones.

Paxton is filing suit against the pharmaceutical giant, which previously sold the drug, the sole analgesic recommended for pregnant women, and Kenvue, which now manufacturers it.

In a official comment, he said they "betrayed America by profiting off of suffering and promoting medication without regard for the risks."

The company states there is lacking scientific proof linking Tylenol to autism.

"These manufacturers misled for generations, knowingly endangering millions to line their pockets," Paxton, from the Republican party, declared.

The manufacturer commented that it was "very worried by the spread of false claims on the reliability of acetaminophen and the possible consequences that could have on the well-being of US mothers and children."

On its official site, the company also mentioned it had "consistently assessed the applicable studies and there is lacking reliable evidence that shows a verified association between consuming paracetamol and autism."

Organizations acting on behalf of physicians and healthcare providers concur.

The American College of Obstetricians and Gynecologists has stated paracetamol - the main ingredient in acetaminophen - is one of the few options for pregnant women to treat pain and elevated temperature, which can present major wellness concerns if ignored.

"In multiple decades of research on the use of acetaminophen in gestation, no reliable research has conclusively proven that the use of acetaminophen in any trimester of pregnancy causes neurological conditions in offspring," the organization stated.

The lawsuit references current declarations from the Trump administration in asserting the medication is reportedly hazardous.

Recently, Trump generated worry from public health officials when he told women during pregnancy to "fight like hell" not to consume Tylenol when sick.

The FDA then issued a notice that doctors should consider limiting the usage of acetaminophen, while also stating that "a direct connection" between the drug and autism spectrum disorder in young ones has remains unverified.

The Health Department head RFK Jr, who oversees the Food and Drug Administration, had promised in spring to initiate "comprehensive study program" that would identify the origin of autism spectrum disorder in a limited time.

But authorities cautioned that finding a sole reason of autism - believed by scientists to be the result of a complex mix of inherited and environmental factors - would be difficult.

Autism is a type of lifelong neurodivergence and impairment that influences how people experience and interact with the world, and is identified using doctors' observations.

In his court filing, the attorney general - who supports Trump who is running for the Senate - asserts Kenvue and Johnson & Johnson "willfully ignored and attempted to silence the evidence" around acetaminophen and autism.

The case attempts to require the firms "destroy any marketing or advertising" that states acetaminophen is secure for women during pregnancy.

The Texas lawsuit parallels the concerns of a group of guardians of children with autism and attention deficit hyperactivity disorder who sued the producers of acetaminophen in 2022.

Judicial authorities dismissed the case, saying studies from the plaintiffs' authorities was inconclusive.